Clincosm LogoSign in Get a demo

Follicular Lymphoma

Showing NaN - NaN of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in United States (JCAR017 (lisocabtagene

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • JCAR017 (lisocabtagene maraleucel) single-dose schedule
  • JCAR017 (lisocabtagene maraleucel) 2-dose schedule
  • Birmingham, Alabama
  • +24 more
Nov 21, 2022

Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)

Active, not recruiting
Has Results
  • Follicular Lymphoma
  • tisagenlecleucel
  • Duarte, California
  • +29 more
Nov 2, 2022

DLBCL, Follicular Lymphoma Trial in United States (Epcoritamab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Fountain Valley, California
  • +38 more
Jul 27, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
Mar 24, 2022

Follicular Lymphoma Trial in United States (Rituximab, Utomilumab, Avelumab)

Active, not recruiting
  • Follicular Lymphoma
  • Duarte, California
  • +5 more
Mar 17, 2022

Follicular Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (Idasanutlin, Obinutuzumab, Venetoclax)

Terminated
Has Results
  • Follicular Lymphoma
  • Lymphoma, Large B-Cell, Diffuse
  • Aurora, Colorado
  • +20 more
Dec 5, 2021

Follicular Lymphoma Trial in Chicago (Venetoclax, Obinutuzumab, CC-486)

Recruiting
  • Follicular Lymphoma
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 12, 2021

Follicular Lymphoma Trial in Chicago (Bortezomib and Tositumomab I-131)

Terminated
Has Results
  • Follicular Lymphoma
  • Bortezomib and Tositumomab I-131
  • Chicago, Illinois
    Rush University Medical Center
Oct 6, 2021

Follicular Lymphoma Trial in Worldwide (ibrutinib, to match ibrutinib, rituximab)

Active, not recruiting
  • Follicular Lymphoma
  • Mobile, Alabama
  • +168 more
Oct 6, 2021

Follicular Lymphoma Trial in Japan, United States (Rituximab, Lenalidomide, Rituximab-CHOP)

Active, not recruiting
  • Follicular Lymphoma
  • Chandler, Arizona
  • +46 more
Jan 8, 2021

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Entospletinib MM
  • Entospletinib SDD
  • Birmingham, Alabama
  • +47 more
Nov 2, 2020

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
May 14, 2020

Follicular Lymphoma, Small Lymphocytic Lymphoma, Lymphoplasmacytic Lymphoma Trial in Worldwide (Idelalisib)

Completed
Has Results
  • Follicular Lymphoma
  • +3 more
  • Fullerton, California
  • +40 more
Jun 14, 2019

DLBCL, Follicular Lymphoma Trial in United States (Ibrutinib, MEDI4736)

Completed
Has Results
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Birmingham, Alabama
  • +10 more
Jun 3, 2019

Follicular Lymphoma Trial in Worldwide (Venetoclax, Bendamustine, Rituximab)

Completed
Has Results
  • Follicular Lymphoma
  • Mobile, Alabama
  • +70 more
Jun 3, 2019

Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564

Completed
  • Acute Myelogenous Leukemia
  • +3 more
  • BMS-936564 (Anti-CXCR4)
  • Birmingham, Alabama
  • +10 more
Mar 5, 2015

Follicular Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in United States (AT-101)

Completed
  • Follicular Lymphoma
  • +4 more
  • Birmingham, Alabama
  • +10 more
Jun 24, 2011

B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

Completed
  • B-Cell Lymphoma
  • +2 more
  • VELCADE and rituximab
  • Los Angeles, California
  • +12 more
Feb 7, 2008